Re: 2012 China (Ji'nan) international performing trade fair and exhibition facilities exhibition will begin today (23) in Ji'nan.
to accept the interview, the Ji'nan hi tech Zone National Tax Bureau staff told reporters that high and new zones like blue gold biology, Xuan Zhu medicine, such as pure R & D enterprises such as many enterprises, R & D enterprises do not receive income tax, increase Value tax, business tax, etc. The proceeds from the transfer of technology will also be exempt from business tax. If the amount is less than 5 million yuan, the enterprise income tax will be levied by half.
"blue gold biological enterprises, we need to keep, we have such enterprises, our bio pharmaceutical industry has a solid foundation, only after the strength." The deputy director of the business service center, Sha Jun, said that the bio pharmaceutical industry is a typical "three high" industry, with high investment, high risk and high return, the foundation must be firmly established. Shandong is a big pharmaceutical Province, but it is not known as a strong pharmaceutical province. Large pharmaceutical factories like Qilu pharmaceutical, which are leading in the province, can only be ranked twentieth in the top 100 list of national pharmaceuticals. Insisting on pharmaceutical R & D is to shorten the distance between Shandong and Shanghai.
like such a drug company, although the research and development has not been effective for a long time, once the new drug is listed, especially the 1.1 new drugs are listed, the influence will be as incalculable as the atomic bomb. The speed of capital withdrawal is also very fast. Many new drugs have a profit of up to 60%-70% after listing, and can recover R & D costs in a few years.
"like the SEK Seth pharmaceutical industry in the pharmaceutical industry park, in 2011, its annual sales changed from 60 million yuan in 2010 to more than 2 billion, as three new drug research and development projects were approved." Sha Jun Ming said that after long research and development, new drugs were finally approved and listed as a carp jumping to Longmen.
[b] with 80 thousand square meters of public rental personnel [/b]
"in Shanghai Zhangjiang Industrial Park, if you want to set up a R & D team, you will be able to find people and pull up the team. It can't be done in Ji'nan at the moment. To do medical research and development, in fact, the final talent is to fight. Dr. Shu Chutian, vice president of medicine of Xuan bamboo, said.
reporter has learned that in recent years, more than 190 talents of "5150" have been introduced in Ji'nan, 147 of them are in high-tech zones, and 86 of them belong to medical talents. Nevertheless, compared with some pharmaceutical industrial parks in Shanghai and Tianjin, talents are still the biggest problem facing the pharmaceutical industry in high-tech zones.
mention the gap between Ji'nan's biological research and development industry and the Beijing Shanghai and other places. Sha Junming, deputy director of the Ji'nan high-tech entrepreneurship service center, also first mentioned the "talent" two words. "The lack of talent is largely due to the fact that we can't compare with the Beijing Shanghai and other areas in the geographical location advantage, which is the objective reason. But we can also give full play to our advantages to keep the park service in place and retain talents. Sha Junming said.
reporter learned that the rising East "Medicine Valley" side, in order to attract talent and retain talent, the construction of 80 thousand square meters of renting supporting construction will also be completed.
[b] biopharmaceuticals are "nice and tasty", and all over the world have taken [/b]
"biopharmaceutical research and development is a good and delicious industry." In the reporter's interview, many enterprises say so. In terms of the current industrial layout of high-tech zones, the information and communication industry is the largest industry, and biopharmaceutical industry is the second largest industry. On the GDP, biopharmaceuticals are not as good as the information industry. At present, a large number of information and software companies do not need to pay taxes due to the state's tax refund policies for export enterprises. The contribution of bio pharmaceutical industry with strong momentum to local finance is much higher than that of information industry. Moreover, medical enterprises occupy less land and ordinary pharmaceutical companies will not exceed 100 mu, and the profits generated after the listing of products will be considerable. The brand aggregation effect of
sophisticated R & D enterprises is also important. Sha Junming told reporters that many enterprises at home and abroad are gathering to the park. In February this year, the world's largest enzyme production enterprise, Denmark also selected the Dani Hi-tech Industrial Park of bio medicine, as the first drop in its external home in Beijing.
[b] enterprise hot hope: use the shared laboratory [/b]
"what we are most hoping for now is that the park can have experimental equipment that can be shared by various pharmaceutical companies." Kang and Pharmaceutical Technology Co., Ltd. relevant person in charge told reporters.
not just Kang and many companies in the interview expressed the same desire. The head of a pharmaceutical research and development company told reporters that many instruments used in medical research and development are valuable, but the utilization rate is not high. For example, an infrared spectrophotometer needs hundreds of thousands of people, and the company's research and development cycle is 3-5 years, and a project is usually used only once, and most of the time, the instrument is idle. It is a waste of resources for small scale R & D enterprises without profit.
Shu Chutian, vice president of medicine of Xuan Zhu, said that there are public open platforms for pharmaceutical experiments in Boston and other places with developed biopharmaceutical industries in the United States. It is generally built by private investment. Each enterprise only needs to pay a small amount of money, so it can use public experimental equipment to do experiments. "The establishment of public laboratories allows R & D institutions to put money on the knife edge. We know that the high tech Zone is building this sharing platform, hoping that the progress will be faster and can be used earlier.
[b]21 million square meters "platform" at the end of the end of the completion of [/b]
[b] "Ji'nan Medicine Valley" is now [/b]
reporter learned that the Ji'nan Hi-tech Zone bio Pharmaceutical Industrial Park base construction is divided into three stages. The first phase is located in the central area of Ji'nan Hi-tech Zone, which has formed a scale of 1 square kilometers of industrial development. It has gathered more than 20 large and medium-sized pharmaceutical R & D, pilot and sales enterprises. The annual sales revenue is nearly 5 billion yuan, the profit tax is nearly 800 million yuan, and the two period is built in the Ji'nan export processing zone, including the national new drug creation. Each stage of the platform will be equipped with technology platform, trial run room and comprehensive incubator base. The three phase will plan and construct 10 thousand mu biological medicine industrial area in Ji'nan high tech Zone. Among them, the "new drug creation platform" is built with the "public laboratory" that pharmaceutical companies look forward to.
21 days, the reporter is located in the export processing zone on the ten East Road, and the main body of the national major special special "Shandong province new drug creation platform" (central test base) is to be sealed up by the Development Zone Investment 780 million. The person in charge of the Hi-tech Zone told the reporter that the platform will be completed by the end of 2012. The original plan was planned to be put into use in June 2013. At present, the hi-tech zone is trying to advance this time to the end of 2012, and the "Ji'nan Medicine Valley" prototype has appeared.
it is understood that the 210 thousand square meters of the national new drug research and development platform center, including 12 unit technology platform for new drug creation public service platform, and the medium test, bio pharmaceutical key laboratory and bio pharmaceutical business incubator, will become the major new drug creation, achievement transformation and pharmaceutical enterprises in the country. Industry intensive areas. It can solve the equipment problems encountered by medical R & D enterprises in experiment and save early investment cost for enterprises. At the same time, the park also introduced medical circulation enterprises such as universal medicine and Kyushu. Once the drug development is successful, these enterprises can provide sales services for R & D enterprises immediately. Realize the industrial chain of R & D, incubation, pilot, production and sales.